Review
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 14, 2011; 17(26): 3101-3108
Published online Jul 14, 2011. doi: 10.3748/wjg.v17.i26.3101
Table 1 Upregulation of heme oxygenase-1 in donor liver to alleviate ischemia-reperfusion injury and rejection
Effective productTargetsResultsRef.
HO-1KCPreventing IRI[4]
HO-1Attenuating apoptosis of SECAlleviating IRI[5]
HO-1Inhibiting DC maturationReducing rejection[6]
HO-1Anti-inflammatory differentiation of KCPreventing IRI[24]
HO-1Modulating oxidative stress and proinflammatory mediatorsAlleviating IRI[30]
COSuppressing T cell proliferationReducing rejection[31]
HO-1MicrochimerismInducing allograft tolerance[41]
COInhibiting TLR-induced DC maturationReducing rejection[42]
HO-1Suppressing intragraft infiltration of KC and neutrophils, preventing proinflammatory cytokine and chemokine expressionAlleviating IRI[50]
HO-1Inducing TregInducing allograft tolerance[56]
BiliverdinDecreasing P-selectin, ICAM-1, iNOS and IL-6Alleviating IRI[60]